These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26216938)

  • 1. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus.
    Spada R; Rojas JM; Barber DF
    J Leukoc Biol; 2015 Oct; 98(4):479-87. PubMed ID: 26216938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional analysis of natural killer cells in systemic lupus erythematosus patients.
    Chiang BL; Chen YC; Wang CR; Lin YL; Chou CC; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):357-63. PubMed ID: 8607362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.
    Hudspeth K; Wang S; Wang J; Rahman S; Smith MA; Casey KA; ; Manna Z; Sanjuan M; Kolbeck R; Hasni S; Ettinger R; Siegel RM
    Clin Exp Immunol; 2019 May; 196(2):226-236. PubMed ID: 30693467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2005 Sep; 17(5):523-8. PubMed ID: 16093828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
    Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in lupus.
    Kang HK; Datta SK
    Int Rev Immunol; 2006; 25(1-2):5-25. PubMed ID: 16531276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons and systemic lupus erythematosus.
    Bankhurst AD
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():63-7. PubMed ID: 2441046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic lupus erythematosus: from pathophysiology to treatment].
    Contin-Bordes C; Lazaro E; Pellegrin JL; Viallard JF; Moreau JF; Blanco P
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H9-13. PubMed ID: 19995652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
    Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K
    Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine panel and histopathological aspects in the systemic lupus erythematosus.
    Avrămescu C; Biciuşcă V; Dăianu T; Turculeanu A; Bălăşoiu M; Popescu SN; Ionete O; Simionescu C
    Rom J Morphol Embryol; 2010; 51(4):633-40. PubMed ID: 21103619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on pathogenesis of systemic lupus erythematosus.
    Ahmadpoor P; Dalili N; Rostami M
    Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory role of Jalpha281 T cells in aged mice developing lupus-like nephritis.
    Sireci G; Russo D; Dieli F; Porcelli SA; Taniguchi M; La Manna MP; Di Liberto D; Scarpa F; Salerno A
    Eur J Immunol; 2007 Feb; 37(2):425-33. PubMed ID: 17273990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of invariant natural killer T cells in lupus and atherogenesis.
    Major AS; Singh RR; Joyce S; Van Kaer L
    Immunol Res; 2006; 34(1):49-66. PubMed ID: 16720898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.